QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SHC

QT75Sotera Health Company
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
15.82
+0.36+2.33%
OverviewShort InterestFilings
SHCQT75Sotera Health Company·NASDAQ
OverviewShort InterestFilings
15.82+2.33%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E37.39EPS (ttm)0.41
Insider Own-
Shs Outstand285.17M
Perf Week-3.48%
Market Cap4.41BForward P/E14.89EPS next Y1.06Insider Trans-19.83%Shs Float-Perf Month3.87%
Enterprise Value6.36BPEG0.10EPS next Q0.24Inst Own-Short Float-Perf Quarter16.67%
Income117.71MP/S3.71EPS this Y137.37%Inst Trans-Short Ratio-Perf Half Y-5.27%
Sales1.19BP/B7.08EPS next Y9.18%ROA3.64%Short Interest-Perf YTD-10.32%
Book/sh2.18P/C17.00EPS next 5Y8.99%ROE20.57%52W High19.85 -20.30%Perf Year44.47%
Cash/sh1.11P/FCF46.51EPS past 3/5Y-ROIC7.96%52W Low10.84 45.94%Perf 3Y-
Dividend Est.-EV/EBITDA13.02Sales past 3/5Y5.05% 7.31%Gross Margin55.01%Volatility2.40% 2.25%Perf 5Y-
Dividend TTM-EV/Sales5.35EPS Y/Y TTM462.50%Oper. Margin35.52%ATR (14)0.51Perf 10Y-
Dividend Ex-Date-Quick Ratio2.52Sales Y/Y TTM8.00%Profit Margin9.91%RSI (14)50.77Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.82EPS Q/Q28.57%SMA200.10%Beta1.25Target Price21.50
Payout0.00%Debt/Eq3.65Sales Q/Q9.80%SMA500.82%Rel Volume1.21Prev Close15.46
Employees3,000LT Debt/Eq3.71EarningsAug 06SMA200-2.59%Avg Volume3.31MPrice15.82
IPO DateNov 20, 2020Option/ShortYes / YesEPS/Sales Surpr.5.88% 3.32%Net Debt/EBITDA4.00Volume3,995,556Change2.33%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-05-26ReiteratedGoldman SachsBuy$17 → $20
Apr-14-26ReiteratedBarclaysOverweight$20 → $18
Jan-09-26UpgradePiper SandlerNeutral → Overweight$17 → $24
Jan-08-26ReiteratedRBC CapitalOutperform$17 → $24
Nov-05-25ReiteratedPiper SandlerNeutral$13 → $17
Nov-05-25ReiteratedBarclaysOverweight$19 → $20
Oct-02-25ReiteratedBarclaysOverweight$17 → $19
May-05-25UpgradeGoldman SachsNeutral → Buy$8.00 → $17
Dec-05-24ReiteratedJefferiesBuy$18 → $15
Nov-06-24ReiteratedJefferiesBuy$15 → $18
Latest News
Jun-16-26
Jun-16-2602:09PM
1 Healthcare Stock for Long-Term Investors and 2 We Turn DownYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,1881,1641,100
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A536518498
Gross Profit655646602
Selling, General and Administrative Excl. Other247253243
Research and Development
000
Other Operating Expense-16062
Operating Income422393298
Interest Expense150156165
Unusual Expense
———
Non-Operating Income (Expense)689019
Net Income Before Taxes205148114
Income Taxes887069
Consolidated Net Income1187844
Net Income From Continuing Operations1187844
Net Income1187844
EPS (Recurring)0.410.270.16
EPS (Basic, Before Extraordinaries)0.410.270.16
EPS (Diluted)0.410.270.16
EBITDA488442442
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio38.5965.33—
Price To Sales Ratio3.804.30—
Gross Margin55.1355.5054.73
Operating Margin35.5233.7627.09
Net Margin9.936.704.00
Shares Outstanding285284283
Market Capitalization4,5095,010—
Operating Lease Expense
———
Insider Trading Volume
$16.73$15.04$13.35$11.66$9.97● Close Price0.00M120.73M241.46M362.19M482.92MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
WARBURG PINCUS & CO.director, 10 percent owner:May 13 '26Sale15.1719,102,952289,753,5760May 15 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:May 13 '26Sale15.1712,735,301193,169,0460May 15 12:00 AM
WARBURG PINCUS & CO.director, 10 percent owner:Mar 06 '26Sale15.2715,000,000229,050,00019,102,952Mar 10 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:Mar 06 '26Sale15.2710,000,000152,700,00012,735,301Mar 10 12:00 AM
Petras Michael B. Jr.Chairman & CEOMar 02 '26Option Exercise0.00179,3720570,835Mar 04 12:00 AM
DIMITRIEF ALEXANDERSVP, General Counsel and Sec.Mar 02 '26Option Exercise0.0033,6320343,600Mar 04 12:00 AM
Lyons Jonathan M.Sr. Vice President, CFOMar 02 '26Option Exercise0.0035,8740201,493Mar 04 12:00 AM
Rutz Michael PPresident of SterigenicsMar 02 '26Option Exercise0.0029,1460456,553Mar 04 12:00 AM
Petras Michael B. Jr.Chairman & CEODec 08 '25Sale16.45750,00012,337,4990Dec 10 12:00 AM
WARBURG PINCUS & CO.director, 10 percent owner:Dec 03 '25Sale16.339,720,000158,727,60034,102,952Dec 05 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:Dec 03 '25Sale16.336,480,000105,818,40022,735,301Dec 05 12:00 AM
WARBURG PINCUS & CO.director, 10 percent owner:Nov 10 '25Sale15.6518,000,000281,718,00043,822,952Nov 12 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:Nov 10 '25Sale15.6512,000,000187,812,00029,215,301Nov 12 12:00 AM
WARBURG PINCUS & CO.director, 10 percent owner:Sep 05 '25Sale15.1112,000,000181,332,00061,822,952Sep 09 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:Sep 05 '25Sale15.118,000,000120,888,00041,215,301Sep 09 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR